Regulation of IL-11 expression in intestinal myofibroblasts: Role of c-Jun AP-1- and MAPK-dependent pathways

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 285, Issue 3 48-3, 2003, Pages

  Bamba, Shigeki ^a   Andoh, Akira ^a   Yasui, Hirofumi ^a   Makino, Jin ^a   Kim, Shokei ^b   Fujiyama, Yoshihide ^a  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^b OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Inflammatory bowel diseases; Interleukin 11; Interleukin 1 ; Transforming growth factor 1

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 HYDROXYPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ADENOVIRUS VECTOR; CD4 ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 11; INTERLEUKIN 1BETA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR AP 1; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL POLARITY; COLON MUCOSA; CONTROLLED STUDY; CROHN DISEASE; CYTOKINE RELEASE; DNA BINDING; ENTERITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION; GENE TRANSFER; HUMAN; HUMAN CELL; INTESTINAL SUBEPITHELIAL MYOFIBROBLAST; INTESTINE CELL; MYOFIBROBLAST; NORTHERN BLOTTING; PATHOGENESIS; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION; TH2 CELL; VIRUS RECOMBINANT;

EID: 0041965736     PISSN: 01931857     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpgi.00050.2003     Document Type: Article

References (48)

1. Alessi DR, Cuenda A, Cohen P, Dudley DT, and Saltiel AR. PD098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. J Biol Chem 270: 27489-27494, 1995.
2. Andoh A, Takaya H, Saotome T, Shimada M, Hata K, Araki Y, Nakamura F, Shintani Y, Fujiyama Y, and Bamba T. Cytokine regulation of chemokine (IL-8, MCP-1, and RANTES) gene expression in human pancreatic periacinar myofibroblasts. Gastroenterology 119: 211-219, 2000.
3. Angel P and Karin M. The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. Biochim Biophys Acta 1072: 129-57, 1991.
4. Bozza M, Bliss JL, Dorner AJ, and Trepicchio WL. Interleukin-11 modulates Th1/Th2 cytokine production from activated CD4+ T cells. J Interferon Cytokine Res 21: 21-30, 2001.
5. Brown PH, Chen TK, and Birrer MJ. Mechanism of action of a dominant-negative mutant of c-Jun. Oncogene 9: 791-799, 1994.
6. Casini-Raggi V, Kam L, Chong YJ, Fiocchi C, Pizarro TT, and Cominelli F. Mucosal imbalance of IL-1 and IL-1 receptor antagonist in inflammatory bowel disease. A novel mechanism of chronic intestinal inflammation. J Immunol 154: 2434-2440, 1995.
7. Chomezynski P and Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156-159, 1987.
8. Cobb MH and Goldsmith EJ. How MAP kinases are regulated. J Biol Chem 270: 14843-14846, 1995.
9. Cuenda A, Rouse J, Doza YN, Meier R, Cohen P, Gallagher TF, Young PR, and Lee JC. SB203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1. FEBS Lett 364: 229-233, 1995.
10. Curti A, Ratta M, Corinti S, Girolomoni G, Ricei F, Tazzari P, Siena M, Grande A, Fogli M, Tura S, and Lemoli RM. Interleukin-11 induces Th2 polarization of human CD4(+) T cells. Blood 97: 2758-2763, 2001.
11. Dean JL, Wait R, Mahtani KR, Sully G, Clark AR, and Saklatvala J. The 3′ untranslated region of tumor necrosis factor alpha mRNA is a target of the mRNA-stabilizing factor HuR. Mol Cell Biol 21: 721-730, 2001.
12. Dignam JD, Lebovitz RM, and Roeder RG. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res 11: 1475-1489, 1983.
13. Dinarello CA. The role of the interleukin-1-receptor antagonist in blocking inflammation mediated by interleukin-1. N Engl J Med 343: 732-734, 2000.
14. Du XX, Doerschuk CM, Orazi A, and Williams DA. A bone marrow stromal-derived growth factor, interleukin-11, stimulates recovery of small intestinal mucosal cells after cytoablative therapy. Blood 83: 33-37, 1994.
15. Elias JA, Zheng T, Whiting NL, Trow TK, Merrill WW, Zitnik R, Ray P, and Alderman EM. IL-1 and transforming growth factor-β regulation of fibroblast-derived IL-11. J Immunol 152: 2421-2429, 1994.
16. Favata MF, Horiuchi KY, Manos EJ, Daulerio AJ, Stradley DA, Feeser WS, Van Dyk DE, Pitts WJ, Earl RA, Hobbs F, Copeland RA, Magolda RL, Scherle PA, and Trzaskos JM. Identification of a novel inhibitor of mitogen-activated protein kinase kinase. J Biol Chem 273: 18623-18632, 1998.
17. Han J, Lee JD, Bibbs L, and Ulevitch RJ. A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells. Science 265: 808-811, 1994.
18. Hata K, Andoh A, Shimada M, Fujino S, Bamba S, Araki Y, Okuno T, Fujiyama Y, and Bamba T. IL-17 stimulates inflammatory responses via NF-κB and MAP kinase pathways in human colonic myofibroblasts. Am J Physiol Gastrointest Liver Physiol 282: G1035-G1044, 2002.
19. Hsu JC, Cressman DE, and Taub R. Promoter-specific transactivation and inhibition mediated by JunB. Cancer Res 53: 3789-3794, 1993.
20. Jobson TM, Billington CK, and Hall IP. Regulation of proliferation of human colonic subepithelial myofibroblasts by mediators important in intestinal inflammation. J Clin Invest 101: 2650-2657, 1998.
21. Karin M, Liu Z, and Zandi E. AP-1 function and regulation. Curr Opin Cell Biol 9: 240-246, 1997.
22. Ling E and Robinson DS. Transforming growth factor-β1: its anti-inflammatory and pro-fibrotic effects. Clin Exp Allergy 32: 175-178, 2002.
23. Liu Q, Du XX, Schinder DT, Yang ZX, Rescorla FJ, Williams DA, Grosfeld JL, Smith S, Hendren WH, Guzzetta PC, and Bruch SW. Trophic effects of interleukin-11 in rats with experimental short bowel syndrome. J Pediatr Surg 31: 1047-1051, 1996.
24. Mahida YR, Beltinger J, Marh S, Goke M, Gray T, Podolsky DK, and Hawkey CJ. Adult human colonic subepithelial myofibroblasts express extracellular matrix proteins and cyclooxygenase-1 and -2. Am J Physiol Gastrointest Liver Physiol 273: G1341-G1348, 1997.
25. Mahtani KR, Brook M, Dean JL, Sully G, Saklatvala J, and Clark AR. Mitogen-activated protein kinase p38 controls the expression and posttranslational modification of tristetraprolin, a regulator of tumor necrosis factor alpha mRNA stability. Mol Cell Biol 21: 6461-6469, 2001.
26. Maier R, Ganu V, and Lotz M. Interleukin-11, an inducible cytokine in human articular chondrocytes and synoviocytes, stimulates the production of the tissue inhibitor of metalloproteinases. J Biol Chem 268: 21527-21532, 1993.
27. Mauviel A, Chung KY, Agarwal A, Tamai K, and Uitto J. Cell-specific induction of distinct oncogenes of the Jun family is responsible for differential regulation of collagenase gene expression by transforming growth factor-β in fibroblasts and keratinocytes. J Biol Chem 271: 10917-10923, 1996.
28. McKaig BC, Hughes K, Tighe PJ, and Mahida YR. Differential expression of TGF-beta isoforms by normal and inflammatory bowel disease intestinal myofibroblasts. Am J Physiol Cell Physiol 282: C172-C182, 2002.
29. McKinley D, Wu Q, Yang-Feng T, and Yang YC. Genomic sequence and chromosomal location of human interleukin-11 gene (IL11). Genomics 13: 814-819, 1992.
30. Minden A and Karin M. Regulation and function of the JNK subgroup of MAP kinases. Biochim Biophys Acta 1333: F85-F104, 1997.
31. Okuno T, Andoh A, Bamba S, Araki Y, Fujiyama Y, Fujiyama M, and Bamba T. Interleukin-1β and tumor necrosis factor-α induce chemokine and matrix metalloproteinase gene expression in human colonic subepithelial myofibroblasts. Scand J Gastroenterol 37: 317-324, 2002.
32. Orazi A, Du X, Yang Z, Kashai M, and Williams DA. Interleukin-11 prevents apoptosis and accelerates recovery of small intestinal mucosa in mice treated with combined chemotherapy and radiation. Lab Invest 75: 33-42, 1996.
33. Paul SR, Bennett F, Calvetti JA, Kelleher K, Wood CR, O'Hara RM Jr, Leary AC, Sibley B, Clark SC, Williams DA, and Yang Y. Molecular cloning of a cDNA encoding interleukin 11, a stromal cell-derived lymphopoietic and hematopoietic cytokine. Proc Natl Acad Sci USA 87: 7512-7516, 1990.
34. Paul SR and Schendel P. The cloning and biological characterization of recombinant human interleukin 11. Int J Cell Cloning 10: 135-143, 1992.
35. Peterson RL, Wang L, Albert L, Keith JC Jr, and Dorner AJ. Molecular effects of recombinant human interleukin-11 in the HLA-B27 rat model of inflammatory bowel disease. Lab Invest 78: 1503-1512, 1998.
36. Powell DW, Mifflin RC, Valentich JD, Crowe SE, Saada JI, and West AB II. Intestinal subepithelial myofibroblasts. Am J Physiol Cell Physiol 277: C183-C201, 1999.
37. Qiu BS, Pfeiffer CJ, and Keith JC Jr. Protection by recombinant human interleukin-11 against experimental TNB-induced colitis in rats. Dig Dis Sci 41: 1625-1630, 1996.
38. Sands BE, Bank S, Sninsky CA, Robinson M, Katz S, Singleton JW, Miner PB, Safdi MA, Galandiuk S, Hanauer SB, Varilek GW, Buchman AL, Rodgers VD, Salzberg B, Cai B, Loewy J, DeBruin MF, Rogge H, Shapiro M, and Schwertschlag US. Preliminary evaluation of safety and activity of recombinant human interleukin 11 in patients with active Crohn's disease. Gastroenterology 117: 58-64, 1999.
39. Sands BE, Winston BD, Salzberg B, Safdi M, Barish C, Wruble L, Wilkins R, Shapiro M, and Schwertschlag US. Crohn's study group. Randomized, controlled trial of recombinant human interleukin-11 in patients with active Crohn's disease. Aliment Pharmacol Ther 16: 399-406, 2002.
40. Schwertsehlag US, Trepicchio WL, Dykstra KH, Keith JC, Turner KJ, and Dorner AJ. Hematopoietic, immunomodulatory and epithelial effects of interleukin-11. Leukemia 13: 1307-1315, 1999.
41. Shimada M, Andoh A, Hata K, Tasaki K, Araki Y, Fujiyama Y, and Bamba T. IL-6 secretion by human pancreatic periacinar myofibroblasts in response to inflammatory mediators. J Immunol 168: 861-868, 2002.
42. Suen Y, Chang M, Lee SM, Buzby JS, and Cairo MS. Regulation of interleukin-11 protein and mRNA expression in neonatal and adult fibroblasts and endothelial cells. Blood 84: 4125-4134, 1994.
43. Taga T. The signal transducer gp130 is shared by interleukin-6 family of haematopoietic and neurotrophic cytokines. Ann Med 29: 63-72, 1997.
44. Tang W, Yang L, Yang YC, Leng SX, and Elias JA. Transforming growth factor-beta stimulates interleukin-11 transcription via complex activating protein-1-dependent pathways. Biol Chem 273: 5506-5513, 1998.
45. Trepicchio WL, Bozza M, Pedneault G, and Dorner AJ. Recombinant human IL-11 attenuates the inflammatory response through down-regulation of proinflammatory cytokine release and nitric oxide production. J Immunol 157: 3627-3634, 1996.
46. Trepicchio WL, Wang L, Bozza M, and Dorner AJ. IL-11 regulates macrophage effector function through the inhibition of nuclear factor-κB. J Immunol 159: 5661-5670, 1997.
47. Yang L and Yang YC. Regulation of interleukin (IL)-11 gene expression in IL-1 induced primate bone marrow stromal cells. J Biol Chem 269: 32732-32739, 1994.
48. Yasumoto H, Kim S, Zhan Y, Miyazaki H, Hoshiga M, Kaneda Y, Morishita R, and Iwao H. Dominant negative c-jun gene transfer inhibits vascular smooth muscle cell proliferation and neointimal hyperplasia in rats. Gene Ther 8: 1682-1689, 2001.